Insight Molecular Diagnostics Inc. Severance Costs
Insight Molecular Diagnostics Inc. (IMDX) reported Severance Costs of $300.00 thousand for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SeveranceCosts1 · last filed 2023-11-09
- Insight Molecular Diagnostics Inc. severance costs for the quarter ending 2023-06-30 was $300.00K, a 200.00% increase year-over-year.
- Insight Molecular Diagnostics Inc. severance costs for the quarter ending 2022-09-30 was $700.00K.
- Insight Molecular Diagnostics Inc. severance costs for the quarter ending 2022-06-30 was $100.00K.
- Insight Molecular Diagnostics Inc. severance costs for the quarter ending 2022-03-31 was $2.30M, a 155.56% increase year-over-year.
- Insight Molecular Diagnostics Inc. severance costs for fiscal 2021 was $2.40M, a 118.18% increase from fiscal 2020.
- Insight Molecular Diagnostics Inc. severance costs for fiscal 2020 was $1.10M.
| Period end | Severance Costs 0 month | Severance Costs 3 month | Severance Costs 6 month | Severance Costs 9 month | Severance Costs 12 month |
|---|---|---|---|---|---|
| 2023-06-30 | $300.00K 10-Q · filed 2023-08-10 | ||||
| 2023-04-12 | $300.00K 10-Q · filed 2023-11-09 | ||||
| 2022-12-31 | $1.90M 10-Q · filed 2023-11-09 | ||||
| 2022-09-30 | $700.00K 10-Q · filed 2022-11-10 | $800.00K derived: sum of 2 quarters · filed 2022-11-10 | $3.10M derived: sum of 3 quarters · filed 2022-11-10 | $5.30M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2022-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $2.40M 10-Q · filed 2022-08-12 | $4.60M derived: sum of 3 quarters · filed 2022-08-12 | $4.20M derived: sum of 4 quarters · filed 2022-08-12 | |
| 2022-03-31 | $2.30M 10-Q · filed 2022-05-12 | $4.50M derived: sum of 2 quarters · filed 2022-05-12 | $4.10M derived: sum of 3 quarters · filed 2022-05-12 | $3.80M derived: sum of 4 quarters · filed 2022-05-12 | |
| 2021-12-31 | $2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $1.80M derived: sum of 2 quarters · filed 2022-03-11 | $1.50M derived: sum of 3 quarters · filed 2022-03-11 | $2.40M 10-K · filed 2022-03-11 | |
| 2021-09-30 | -$400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$700.00K derived: sum of 2 quarters · filed 2021-11-09 | $200.00K 10-Q · filed 2021-11-09 | $0.00 derived: sum of 4 quarters · filed 2021-11-09 | |
| 2021-06-30 | -$300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $600.00K 10-Q · filed 2021-08-11 | $400.00K derived: sum of 3 quarters · filed 2021-08-11 | ||
| 2021-03-31 | $900.00K 10-Q · filed 2021-05-17 | $700.00K derived: sum of 2 quarters · filed 2021-05-17 | |||
| 2020-12-31 | -$200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-19 | $1.10M 10-K · filed 2021-03-19 | |||
| 2020-09-30 | $1.30M 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |